1.

Archeologische resultaten van de VLIZ-prospecties op het strand Oostende-Oosteroever in 2013-2014. Een eerste analyse

2.

Archeologische resultaten van de VLIZ-prospecties op het strand Oostende-Oosteroever in 2013-2014. Een eerste analyse

1.

The Precariousness of Walloon Peri-Urban Agricultural Lands

2.

The Precariousness of Walloon Peri-Urban Agricultural Lands

3.

The Precariousness of Walloon Peri-Urban Agricultural Lands

4.

The Precariousness of Walloon Peri-Urban Agricultural Lands

5.

The Precariousness of Walloon Peri-Urban Agricultural Lands

6.

The Precariousness of Walloon Peri-Urban Agricultural Lands

7.

The Precariousness of Walloon Peri-Urban Agricultural Lands

8.

The Precariousness of Walloon Peri-Urban Agricultural Lands

9.

The Precariousness of Walloon Peri-Urban Agricultural Lands

1.

Établissement de scénarios alternatifs de valorisations alimentaires et non alimentaires des ressources céréalières wallonnes à l’horizon 2030 ; Alternative scenarios for food and...

2.

Établissement de scénarios alternatifs de valorisations alimentaires et non alimentaires des ressources céréalières wallonnes à l’horizon 2030 ; Alternative scenarios for food and...

3.

Établissement de scénarios alternatifs de valorisations alimentaires et non alimentaires des ressources céréalières wallonnes à l’horizon 2030 ; Alternative scenarios for food and...

4.

Établissement de scénarios alternatifs de valorisations alimentaires et non alimentaires des ressources céréalières wallonnes à l’horizon 2030 ; Alternative scenarios for food and...

5.

Établissement de scénarios alternatifs de valorisations alimentaires et non alimentaires des ressources céréalières wallonnes à l’horizon 2030 ; Alternative scenarios for food and...

6.

Établissement de scénarios alternatifs de valorisations alimentaires et non alimentaires des ressources céréalières wallonnes à l’horizon 2030 ; Alternative scenarios for food and...

7.

Établissement de scénarios alternatifs de valorisations alimentaires et non alimentaires des ressources céréalières wallonnes à l’horizon 2030 ; Alternative scenarios for food and...

8.

Établissement de scénarios alternatifs de valorisations alimentaires et non alimentaires des ressources céréalières wallonnes à l’horizon 2030 ; Alternative scenarios for food and...

9.

Établissement de scénarios alternatifs de valorisations alimentaires et non alimentaires des ressources céréalières wallonnes à l’horizon 2030 ; Alternative scenarios for food and...

1.

A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MAD...

2.

A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MAD...

3.

A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MAD...

4.

A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MAD...

5.

A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MAD...

1.

Belgian guidelines for pathology reporting of neuroendocrine neoplasms of the pancreaticobiliary and gastrointestinal tract. Initialized by the Belgian Group of Digestive Oncology...

2.

Belgian guidelines for pathology reporting of neuroendocrine neoplasms of the pancreaticobiliary and gastrointestinal tract. Initialized by the Belgian Group of Digestive Oncology...

3.

Belgian guidelines for pathology reporting of neuroendocrine neoplasms of the pancreaticobiliary and gastrointestinal tract. Initialized by the Belgian Group of Digestive Oncology...

4.

Belgian guidelines for pathology reporting of neuroendocrine neoplasms of the pancreaticobiliary and gastrointestinal tract. Initialized by the Belgian Group of Digestive Oncology...

5.

Belgian guidelines for pathology reporting of neuroendocrine neoplasms of the pancreaticobiliary and gastrointestinal tract. Initialized by the Belgian Group of Digestive Oncology...

6.

Belgian guidelines for pathology reporting of neuroendocrine neoplasms of the pancreaticobiliary and gastrointestinal tract. Initialized by the Belgian Group of Digestive Oncology...

7.

Belgian guidelines for pathology reporting of neuroendocrine neoplasms of the pancreaticobiliary and gastrointestinal tract. Initialized by the Belgian Group of Digestive Oncology...

1.

Etablissement de scénarios alternatifs de valorisations alimentaires et non alimentaires des ressources céréalières wallonnes à l'horizon 2030

2.

Etablissement de scénarios alternatifs de valorisations alimentaires et non alimentaires des ressources céréalières wallonnes à l'horizon 2030

3.

Etablissement de scénarios alternatifs de valorisations alimentaires et non alimentaires des ressources céréalières wallonnes à l'horizon 2030

4.

Etablissement de scénarios alternatifs de valorisations alimentaires et non alimentaires des ressources céréalières wallonnes à l'horizon 2030

5.

Etablissement de scénarios alternatifs de valorisations alimentaires et non alimentaires des ressources céréalières wallonnes à l'horizon 2030

1.

Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients

2.

Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients

3.

Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients

4.

Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients

5.

Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients

1.

Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab.

2.

Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab.

3.

Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab.

4.

Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab.

5.

Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab.

6.

Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab.

7.

Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab.

8.

Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab.

1.

SPICT as a predictive tool for risk of 1-year health degradation and death in older patients admitted to the emergency department: a bicentric cohort study in Belgium.

2.

SPICT as a predictive tool for risk of 1-year health degradation and death in older patients admitted to the emergency department: a bicentric cohort study in Belgium.

3.

SPICT as a predictive tool for risk of 1-year health degradation and death in older patients admitted to the emergency department: a bicentric cohort study in Belgium.

4.

SPICT as a predictive tool for risk of 1-year health degradation and death in older patients admitted to the emergency department: a bicentric cohort study in Belgium.

5.

SPICT as a predictive tool for risk of 1-year health degradation and death in older patients admitted to the emergency department: a bicentric cohort study in Belgium.

6.

SPICT as a predictive tool for risk of 1-year health degradation and death in older patients admitted to the emergency department: a bicentric cohort study in Belgium.

7.

SPICT as a predictive tool for risk of 1-year health degradation and death in older patients admitted to the emergency department: a bicentric cohort study in Belgium.

8.

SPICT as a predictive tool for risk of 1-year health degradation and death in older patients admitted to the emergency department: a bicentric cohort study in Belgium.

9.

SPICT as a predictive tool for risk of 1-year health degradation and death in older patients admitted to the emergency department: a bicentric cohort study in Belgium.

1.

The BELFRAIL (BFC80+) study : a population-based prospective cohort study of the very elderly in Belgium

2.

The BELFRAIL (BFC80+) study : a population-based prospective cohort study of the very elderly in Belgium

3.

The BELFRAIL (BFC80+) study : a population-based prospective cohort study of the very elderly in Belgium

4.

The BELFRAIL (BFC80+) study : a population-based prospective cohort study of the very elderly in Belgium

5.

The BELFRAIL (BFC80+) study : a population-based prospective cohort study of the very elderly in Belgium

6.

The BELFRAIL (BFC80+) study : a population-based prospective cohort study of the very elderly in Belgium

7.

The BELFRAIL (BFC80+) study : a population-based prospective cohort study of the very elderly in Belgium

8.

The BELFRAIL (BFC80+) study : a population-based prospective cohort study of the very elderly in Belgium

9.

The BELFRAIL (BFC80+) study : a population-based prospective cohort study of the very elderly in Belgium